Selcuk Sozer, Ph.D. - Publications

Affiliations: 
2004 University of Kentucky, Lexington, KY 
Area:
Molecular Biology, Oncology

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Şoroğlu CV, Uslu-Bıçak İ, Toprak SF, Yavuz AS, Sözer S. Effect of hypoxia on HIF-1α and NOS3 expressions in CD34 cells of JAK2V617F-positive myeloproliferative neoplasms. Advances in Medical Sciences. 68: 169-175. PMID 37075583 DOI: 10.1016/j.advms.2023.03.003  0.396
2022 Uslu Bıçak I, Tokcan B, Yavuz AS, Sözer S. Circulating CD133 CD34 progenitors have increased c-MYC expressions in Myeloproliferative Neoplasms. Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology. PMID 36458557 DOI: 10.4274/tjh.galenos.2022.2022.0343  0.446
2011 Sozer S, Hoffman R. Laser-capture microdissection and analysis of liver endothelial cells from patients with Budd-Chiari syndrome. Methods in Molecular Biology (Clifton, N.J.). 755: 405-15. PMID 21761323 DOI: 10.1007/978-1-61779-163-5_34  0.306
2009 Sozer S, Ishii T, Fiel MI, Wang J, Wang X, Zhang W, Godbold J, Xu M, Hoffman R. Human CD34+ cells are capable of generating normal and JAK2V617F positive endothelial like cells in vivo. Blood Cells, Molecules & Diseases. 43: 304-12. PMID 19762257 DOI: 10.1016/J.Bcmd.2009.08.005  0.566
2009 Wang X, Zhang W, Ishii T, Sozer S, Wang J, Xu M, Hoffman R. Correction of the abnormal trafficking of primary myelofibrosis CD34+ cells by treatment with chromatin-modifying agents. Cancer Research. 69: 7612-8. PMID 19752087 DOI: 10.1182/Blood.V112.11.101.101  0.505
2008 Sozer S, Wang X, Zhang W, Fiel MI, Ishii T, Wang J, Wisch N, Xu M, Hoffman R. Circulating angiogenic monocyte progenitor cells are reduced in JAK2V617F high allele burden myeloproliferative disorders. Blood Cells, Molecules & Diseases. 41: 284-91. PMID 18715806 DOI: 10.1016/J.Bcmd.2008.06.008  0.413
2007 Ishii T, Zhao Y, Sozer S, Shi J, Zhang W, Hoffman R, Xu M. Behavior of CD34+ cells isolated from patients with polycythemia vera in NOD/SCID mice. Experimental Hematology. 35: 1633-40. PMID 17764815 DOI: 10.1016/J.Exphem.2007.07.005  0.475
2007 Shi J, Zhao Y, Ishii T, Hu W, Sozer S, Zhang W, Bruno E, Lindgren V, Xu M, Hoffman R. Effects of chromatin-modifying agents on CD34+ cells from patients with idiopathic myelofibrosis. Cancer Research. 67: 6417-24. PMID 17616702 DOI: 10.1158/0008-5472.CAN-07-0572  0.495
2007 Neering SJ, Bushnell T, Sozer S, Ashton J, Rossi RM, Wang PY, Bell DR, Heinrich D, Bottaro A, Jordan CT. Leukemia stem cells in a genetically defined murine model of blast-crisis CML. Blood. 110: 2578-85. PMID 17601986 DOI: 10.1182/Blood-2007-02-073031  0.39
2004 Sozer S, Echlin DR, Rossi RM, Grimes BA, Jordan CT. Characterization and Functional Analysis of a Murine Model for Chronic Myeloid Leukemia Stem Cells. Blood. 104: 4476-4476. DOI: 10.1182/Blood.V104.11.4476.4476  0.403
Show low-probability matches.